# Boston Scientific Corp: filings

BSX · NYSE · CIK 885725 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bsx.md) · [Financials](/companies/bsx/financials.md) · [Filings](/companies/bsx/filings.md) · [Insiders](/companies/bsx/insiders.md)

## Reports and events: 394 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 2725, 8-K 298, 144 109, SC 13G/A 65, 3 54, 10-Q 53, DEFA14A 23, 4/A 22, SC 13G 20, 10-K 18, 11-K 18, DEF 14A 18, UPLOAD 17, SD 13, 424B2 11, ARS 11, FWP 11, 424B5 10, CORRESP 10, 425 9, S-8 7, S-3ASR 6, SCHEDULE 13G/A 6, 3/A 4, 424B3 4, PRE 14A 4, SC TO-T/A 4, 10-K/A 3, 8-K/A 3, 5 2, 8-A12B 2, CERT 2, 10-Q/A 1, 144/A 1, 25-NSE 1, DEFR14A 1, EFFECT 1, S-4 1, S-4/A 1, SCHEDULE 13G 1, SC TO-C 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 06:11 ET | [8-K](/filings/0000885725-26-000064.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000064 |
| 2026-09-23 | 06:01 ET | [8-K](/filings/0000885725-26-000061.md) | 5.02 Departure or appointment of officers or directors | 0000885725-26-000061 |
| 2026-09-08 | 06:15 ET | [8-K](/filings/0000885725-26-000059.md) | 1.05 Material cybersecurity incident | 0000885725-26-000059 |
| 2026-08-26 | 06:06 ET | [8-K](/filings/0000885725-26-000056.md) | 8.01 Other events | 0000885725-26-000056 |
| 2026-08-03 | 06:32 ET | [10-Q](/filings/0000885725-26-000053.md) | Quarterly report, period 2026-06-30 | 0000885725-26-000053 |
| 2026-07-29 | 06:33 ET | [8-K](/filings/0000885725-26-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-26-000051 |
| 2026-07-27 | 16:06 ET | [8-K](/filings/0000885725-26-000049.md) | 2.05 Exit or disposal costs | 0000885725-26-000049 |
| 2026-05-18 | 07:17 ET | [8-K](/filings/0000885725-26-000042.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000042 |
| 2026-05-18 | 07:15 ET | [8-K](/filings/0000885725-26-000041.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000041 |
| 2026-05-05 | 16:47 ET | [8-K](/filings/0000885725-26-000036.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000885725-26-000036 |
| 2026-05-01 | 06:25 ET | [10-Q](/filings/0000885725-26-000033.md) | Quarterly report, period 2026-03-31 | 0000885725-26-000033 |
| 2026-04-22 | 06:34 ET | [8-K](/filings/0000885725-26-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-26-000031 |
| 2026-03-30 | 06:14 ET | [8-K](/filings/0000885725-26-000029.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000029 |
| 2026-03-18 | 16:56 ET | [DEF 14A](/filings/0000885725-26-000025.md) | Proxy statement, period 2026-03-18 | 0000885725-26-000025 |
| 2026-02-26 | 17:11 ET | [8-K](/filings/0000885725-26-000017.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000885725-26-000017 |
| 2026-02-23 | 16:33 ET | [8-K](/filings/0000885725-26-000013.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-26-000013 |
| 2026-02-17 | 16:08 ET | [10-K](/filings/0000885725-26-000010.md) | Annual report, period 2025-12-31 | 0000885725-26-000010 |
| 2026-02-05 | 16:21 ET | [8-K](/filings/0000885725-26-000008.md) | 5.02 Departure or appointment of officers or directors | 0000885725-26-000008 |
| 2026-02-04 | 06:33 ET | [8-K](/filings/0000885725-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-26-000006 |
| 2026-01-15 | 17:05 ET | [8-K](/filings/0000947871-26-000037.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000947871-26-000037 |
| 2026-01-15 | 07:21 ET | [8-K](/filings/0000947871-26-000034.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-26-000034 |
| 2025-11-19 | 16:20 ET | [8-K](/filings/0000885725-25-000052.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-25-000052 |
| 2025-11-03 | 06:31 ET | [10-Q](/filings/0000885725-25-000050.md) | Quarterly report, period 2025-09-30 | 0000885725-25-000050 |
| 2025-10-23 | 16:21 ET | [8-K](/filings/0000885725-25-000048.md) | 5.02 Departure or appointment of officers or directors | 0000885725-25-000048 |
| 2025-10-22 | 06:32 ET | [8-K](/filings/0000885725-25-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-25-000046 |
| 2025-09-04 | 16:07 ET | [8-K](/filings/0000885725-25-000043.md) | 5.02 Departure or appointment of officers or directors | 0000885725-25-000043 |
| 2025-08-01 | 06:32 ET | [10-Q](/filings/0000885725-25-000041.md) | Quarterly report, period 2025-06-30 | 0000885725-25-000041 |
| 2025-07-23 | 06:32 ET | [8-K](/filings/0000885725-25-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-25-000039 |
| 2025-05-28 | 07:45 ET | [8-K](/filings/0000885725-25-000033.md) | 8.01 Other events | 0000885725-25-000033 |
| 2025-05-06 | 16:26 ET | [8-K](/filings/0000885725-25-000028.md) | 5.07 Shareholder vote results | 0000885725-25-000028 |
| 2025-05-01 | 06:31 ET | [10-Q](/filings/0000885725-25-000026.md) | Quarterly report, period 2025-03-31 | 0000885725-25-000026 |
| 2025-04-23 | 06:48 ET | [8-K](/filings/0000885725-25-000024.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-25-000024 |
| 2025-04-23 | 06:34 ET | [8-K](/filings/0000885725-25-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-25-000023 |
| 2025-03-19 | 16:27 ET | [DEF 14A](/filings/0000885725-25-000017.md) | Proxy statement, period 2025-03-19 | 0000885725-25-000017 |
| 2025-02-26 | 16:27 ET | [8-K](/filings/0000885725-25-000013.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-25-000013 |
| 2025-02-18 | 16:13 ET | [10-K](/filings/0000885725-25-000011.md) | Annual report, period 2024-12-31 | 0000885725-25-000011 |
| 2025-02-12 | 16:09 ET | [8-K](/filings/0000885725-25-000009.md) | 5.02 Departure or appointment of officers or directors | 0000885725-25-000009 |
| 2025-02-05 | 06:41 ET | [8-K](/filings/0000885725-25-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-25-000007 |
| 2025-01-16 | 16:26 ET | [8-K](/filings/0000885725-25-000003.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-25-000003 |
| 2024-11-22 | 16:18 ET | [8-K](/filings/0000885725-24-000081.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885725-24-000081 |
| 2024-11-15 | 16:02 ET | [8-K](/filings/0000885725-24-000078.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-24-000078 |
| 2024-11-07 | 07:00 ET | [8-K](/filings/0000885725-24-000075.md) | 7.01 Regulation FD disclosure | 0000885725-24-000075 |
| 2024-11-01 | 06:33 ET | [10-Q](/filings/0000885725-24-000073.md) | Quarterly report, period 2024-09-30 | 0000885725-24-000073 |
| 2024-10-23 | 06:32 ET | [8-K](/filings/0000885725-24-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-24-000070 |
| 2024-08-01 | 16:16 ET | [10-Q](/filings/0000885725-24-000068.md) | Quarterly report, period 2024-06-30 | 0000885725-24-000068 |
| 2024-07-30 | 16:18 ET | [8-K](/filings/0000885725-24-000063.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885725-24-000063 |
| 2024-07-24 | 06:35 ET | [8-K](/filings/0000885725-24-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885725-24-000060 |
| 2024-05-10 | 16:20 ET | [8-K](/filings/0000885725-24-000050.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885725-24-000050 |
| 2024-05-06 | 16:13 ET | [8-K](/filings/0000885725-24-000048.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000885725-24-000048 |
| 2024-05-01 | 16:05 ET | [10-Q](/filings/0000885725-24-000046.md) | Quarterly report, period 2024-03-31 | 0000885725-24-000046 |

Page 1 of 8. [Older](/companies/bsx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 06:35 ET. No prices; not investment advice.